Skip to content

Clinical trials

Completed Schizophrenia trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: Czechia Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20044
20053
20061
20072
20083
20091
20103
20113
20121
20132
20151
20164
20171
20181
20191
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lundbeck A/S4
Janssen-Cilag International NV4
Otsuka Pharmaceutical Development & Commercialization, Inc.4
ACADIA Pharmaceuticals Inc.3
Hoffmann-La Roche3
Eli Lilly and Company2
Janssen Research & Development, LLC2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Alkermes, Inc.1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia37
Psychotic Disorders5
Cognitive Dysfunction2
Recurrence2
Adjustment Disorders1
Anxiety Disorders1
Bipolar Disorder1
Cognition Disorders1
Depressive Disorder1
Major Depressive Disorder1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.